The latest, biggest stories on scientific research, legal developments, and economic trends in the CBD world.
CBD Legal Developments
A watershed moment, as the US government finally initiates research into CBD as a medicine. Also, a strange story out of Kentucky: one CBD company suing another?
The National Institute of Health (NIH) announced nine new research grants worth a total of $3 million dollars to institutions like the University of California San Francisco (UCSF) and the University of Utah.
These grants are a direct response to the 2017 National Academy of Sciences, Engineering, and Medicine request for more research into the health-related applications of cannabis. The announced intent of these studies is to investigate CBD as an alternative painkiller.
This one’s a first: the 2019 crop of a Kentucky-based CBD producer was a failure, and they claim that an Oregon hemp seed seller is to blame. The Kentucky company claims that the seller “sold [them] more than 6 million seeds that were mostly “male” instead of “feminized,” as promised. The suit says male seeds sell for less than a penny each while feminized seeds cost as must as $1 each because female plants produce a CBD-rich flower.”
Another study indicates that CBD may counteract negative brain-effects of THC. A major US disease foundation has released CBD guidelines, while scientists explore CBD’s potential as a treatment for autism.
THC has long been associated with certain psychiatric disorders, and this study suggested “a potential mechanism by which CBD may counteract the psychotomimetic and psychotropic side-effects of THC.” Translation: THC dysregulates certain brain functions, and CBD can potentially reverse these effects.
This research is motivated by similarities in the onset of epilepsy and autism, considering that CBD is proven effective as a treatment for epilepsy.
Symptoms associated with autism, “loss of cognitive function, poor socializing skills, poor language skills — what you’re looking at is a phenotype very similar to autism,” GW founder Dr. Geoffrey Guy told Gupta during a rare tour greenhouse tour. “In my mind, epilepsy and autism-type presentations are on the same continuum.”
Arthritis and joint pain are two of the most common maladies treated with CBD, and the Arthritis Foundation has responded to CBD’s growing popularity with a set of usage guidelines. They emphasize finding a trusted, lab-tested brand and slowly ramping up dosage for first-time users.
CBD Business Developments
A new series of tests find that many CBD brands inaccurately label the amount of CBD in their products. American Eagle becomes the first youth-oriented store to sell CBD.
Only four of the tested brands had the exact amount of CBD on the label, two had 60-80% of the amount claimed, and two had more than claimed.
First, it was CVS, Walgreens, and Kroger who started carrying CBD products nationwide. The next group of national CBD retailers was even more interesting: upscale health and beauty stores like Neiman Marcus and Sephora. Now, it’s American Eagle, a youthful clothing brand that caters to the younger demographic more than any national retailer to start selling CBD yet.
This may be a response to statistics indicating that CBD is particularly popular among younger demographics.